chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 67.0
Sex: U
Vaccine: COVID19
Symptoms: Nasopharyngitis, SARS-CoV-2 test, Sinus headache, Vaccination complication
Clinical narrative: Felt like something in her chest like a bomb after getting 3rd dose; Had a cold; felt like a flu; she had sever reaction after receiving 3rd dose; Could lift her head up off the pillow this time; Patient is still experiencing little fatigue; little bit of a headache that is more toward sinus; This spontaneous case was reported by a consumer and describes the occurrence of CHEST DISCOMFORT (Felt like something in her chest like a bomb after getting 3rd dose), NASOPHARYNGITIS (Had a cold), INFLUENZA (felt like a flu), SINUS HEADACHE (little bit of a headache that is more toward sinus) and VACCINATION COMPLICATION (she had sever reaction after receiving 3rd dose) in a 67-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Non-smoker and Vaccination adverse reaction. Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) and VITAMINS NOS for an unknown indication.    On 07-Sep-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Sep-2021, the patient experienced SINUS HEADACHE (little bit of a headache that is more toward sinus). On an unknown date, the patient experienced CHEST DISCOMFORT (Felt like something in her chest like a bomb after getting 3rd dose), NASOPHARYNGITIS (Had a cold), INFLUENZA (felt like a flu), VACCINATION COMPLICATION (she had sever reaction after receiving 3rd dose), HEAD DISCOMFORT (Could lift her head up off the pillow this time) and FATIGUE (Patient is still experiencing little fatigue). The patient was treated with AZITHROMYCIN (Z-PAK) on 19-Sep-2021 for Adverse event, at an unspecified dose and frequency. At the time of the report, CHEST DISCOMFORT (Felt like something in her chest like a bomb after getting 3rd dose) and HEAD DISCOMFORT (Could lift her head up off the pillow this time) outcome was unknown and NASOPHARYNGITIS (Had a cold), INFLUENZA (felt like a flu), SINUS HEADACHE (little bit of a headache that is more toward sinus), VACCINATION COMPLICATION (she had sever reaction after receiving 3rd dose) and FATIGUE (Patient is still experiencing little fatigue) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 09-Sep-2021, SARS-CoV-2 test: negative (Negative) Negative and. On 15-Sep-2021, SARS-CoV-2 test: positive (Positive) Positive. On an unknown date, Body temperature: abnormal (abnormal) Had temperature.         Patient went on PCR COVID-19 test on 28-Sep-2021.   This case was linked to MOD-2021-334391, MOD-2021-335705 (Patient Link).
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Illness, Lethargy, Pyrexia
Clinical narrative: sick with all three doses; lethargic after dose 1; fever not above a 100°F after dose 1; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (sick with all three doses), LETHARGY (lethargic after dose 1) and PYREXIA (fever not above a 100°F after dose 1) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Jan-2021, the patient experienced LETHARGY (lethargic after dose 1) and PYREXIA (fever not above a 100°F after dose 1). On an unknown date, the patient experienced ILLNESS (sick with all three doses). The patient was treated with PARACETAMOL (TYLENOL) for Fever, at an unspecified dose and frequency and IBUPROFEN SODIUM (IBUPROFEN [IBUPROFEN SODIUM]) for Fever, at an unspecified dose and frequency. On 10-Jan-2021, LETHARGY (lethargic after dose 1) and PYREXIA (fever not above a 100°F after dose 1) had resolved. At the time of the report, ILLNESS (sick with all three doses) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported. No treatment medication was reported.   This case was linked to MOD-2021-335764, MOD-2021-335775 (Patient Link).
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Illness, Pyrexia, Urinary tract infection, Vaccination complication, Vomiting
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (sick with all three doses), URINARY TRACT INFECTION (A week after dose 2 got UTI), VACCINATION COMPLICATION (second and third dose had an impact on her hormones), VULVOVAGINAL DRYNESS (dry vagina) and PYREXIA (fever not above a 100°F after dose 1) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 041L20A, 013M20A and 004F21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.    On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-Sep-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-Jan-2021, the patient experienced PYREXIA (fever not above a 100°F after dose 1). On an unknown date, the patient experienced ILLNESS (sick with all three doses), URINARY TRACT INFECTION (A week after dose 2 got UTI), VACCINATION COMPLICATION (second and third dose had an impact on her hormones), VULVOVAGINAL DRYNESS (dry vagina) and VOMITING (vomited after dose 2). The patient was treated with IBUPROFEN for Adverse event, at an unspecified dose and frequency and ESTRADIOL for Vaginal dryness, at an unspecified dose and frequency. On 10-Jan-2021, PYREXIA (fever not above a 100°F after dose 1) outcome was unknown. At the time of the report, ILLNESS (sick with all three doses), URINARY TRACT INFECTION (A week after dose 2 got UTI), VACCINATION COMPLICATION (second and third dose had an impact on her hormones), VULVOVAGINAL DRYNESS (dry vagina) and VOMITING (vomited after dose 2) outcome was unknown.            No concomitant medications were reported.   This case was linked to MOD-2021-335745 (Patient Link).
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Vulvovaginal dryness
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (sick with all three doses), URINARY TRACT INFECTION (A week after dose 2 got UTI), VACCINATION COMPLICATION (second and third dose had an impact on her hormones), VULVOVAGINAL DRYNESS (dry vagina) and PYREXIA (fever not above a 100°F after dose 1) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 041L20A, 013M20A and 004F21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.    On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-Sep-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-Jan-2021, the patient experienced PYREXIA (fever not above a 100°F after dose 1). On an unknown date, the patient experienced ILLNESS (sick with all three doses), URINARY TRACT INFECTION (A week after dose 2 got UTI), VACCINATION COMPLICATION (second and third dose had an impact on her hormones), VULVOVAGINAL DRYNESS (dry vagina) and VOMITING (vomited after dose 2). The patient was treated with IBUPROFEN for Adverse event, at an unspecified dose and frequency and ESTRADIOL for Vaginal dryness, at an unspecified dose and frequency. On 10-Jan-2021, PYREXIA (fever not above a 100°F after dose 1) outcome was unknown. At the time of the report, ILLNESS (sick with all three doses), URINARY TRACT INFECTION (A week after dose 2 got UTI), VACCINATION COMPLICATION (second and third dose had an impact on her hormones), VULVOVAGINAL DRYNESS (dry vagina) and VOMITING (vomited after dose 2) outcome was unknown.            No concomitant medications were reported.   This case was linked to MOD-2021-335745 (Patient Link).
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: Positive for Covid-19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Positive for Covid-19) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (Positive for Covid-19). At the time of the report, COVID-19 (Positive for Covid-19) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: positive (Positive) positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications was not provided by the reporter Treatment information was not provided; Sender's Comments: This case concerns a male patient of unknown age with no relevant medical history reported who experienced non serious unexpected event of special interest COVID-19. The event occurred unknown time after the first dose of Spikevax. Rechallenge was unknown since there is no information regarding the second dose. The benefit-risk relationship of drug is not affected by this report. The patient experienced COVID-19 prior to second dose administration.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Mildly sore arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Mildly sore arm) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Dec-2020, the patient experienced VACCINATION SITE PAIN (Mildly sore arm). At the time of the report, VACCINATION SITE PAIN (Mildly sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication was not provided.  Treatment information was not provided.   This case was linked to MOD-2021-335979, MOD-2021-335982 (Patient Link).
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Chills, Lethargy, Malaise
Clinical narrative: vaginal bleeding; lethargic; upper and lower back pain/pain in her upper back; didn't feel good; general aches and pains like she had the flu; a little nauseous; pain around her shoulders; chills; injection site was tender to the touch/injection site pain/tender to the touch; injection site was raised/raised bump at the injection site; injection site bruised/bruising around the injection site; bled a lot after the injection; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (injection site was raised/raised bump at the injection site), VACCINATION SITE BRUISING (injection site bruised/bruising around the injection site), VAGINAL HAEMORRHAGE (vaginal bleeding), LETHARGY (lethargic) and BACK PAIN (upper and lower back pain/pain in her upper back) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 091D21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 03-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Aug-2021, the patient experienced VACCINATION SITE MASS (injection site was raised/raised bump at the injection site), VACCINATION SITE BRUISING (injection site bruised/bruising around the injection site), VACCINATION SITE HAEMORRHAGE (bled a lot after the injection) and VACCINATION SITE PAIN (injection site was tender to the touch/injection site pain/tender to the touch). On 04-Aug-2021, the patient experienced VAGINAL HAEMORRHAGE (vaginal bleeding), LETHARGY (lethargic), BACK PAIN (upper and lower back pain/pain in her upper back), MALAISE (didn't feel good), PAIN (general aches and pains like she had the flu), NAUSEA (a little nauseous), ARTHRALGIA (pain around her shoulders) and CHILLS (chills). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. On 06-Aug-2021, PAIN (general aches and pains like she had the flu) had resolved. In August 2021, BACK PAIN (upper and lower back pain/pain in her upper back) and ARTHRALGIA (pain around her shoulders) had resolved. At the time of the report, VACCINATION SITE MASS (injection site was raised/raised bump at the injection site), VACCINATION SITE BRUISING (injection site bruised/bruising around the injection site), LETHARGY (lethargic), MALAISE (didn't feel good), VACCINATION SITE HAEMORRHAGE (bled a lot after the injection), NAUSEA (a little nauseous), VACCINATION SITE PAIN (injection site was tender to the touch/injection site pain/tender to the touch) and CHILLS (chills) outcome was unknown and VAGINAL HAEMORRHAGE (vaginal bleeding) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. Treatment includes Ice and Tea   This case was linked to MOD-2021-336033 (Patient Link).
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pain, Vaccination site bruising, Vaccination site haemorrhage, Vaccination site mass
Clinical narrative: vaginal bleeding; lethargic; upper and lower back pain/pain in her upper back; didn't feel good; general aches and pains like she had the flu; a little nauseous; pain around her shoulders; chills; injection site was tender to the touch/injection site pain/tender to the touch; injection site was raised/raised bump at the injection site; injection site bruised/bruising around the injection site; bled a lot after the injection; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (injection site was raised/raised bump at the injection site), VACCINATION SITE BRUISING (injection site bruised/bruising around the injection site), VAGINAL HAEMORRHAGE (vaginal bleeding), LETHARGY (lethargic) and BACK PAIN (upper and lower back pain/pain in her upper back) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 091D21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 03-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Aug-2021, the patient experienced VACCINATION SITE MASS (injection site was raised/raised bump at the injection site), VACCINATION SITE BRUISING (injection site bruised/bruising around the injection site), VACCINATION SITE HAEMORRHAGE (bled a lot after the injection) and VACCINATION SITE PAIN (injection site was tender to the touch/injection site pain/tender to the touch). On 04-Aug-2021, the patient experienced VAGINAL HAEMORRHAGE (vaginal bleeding), LETHARGY (lethargic), BACK PAIN (upper and lower back pain/pain in her upper back), MALAISE (didn't feel good), PAIN (general aches and pains like she had the flu), NAUSEA (a little nauseous), ARTHRALGIA (pain around her shoulders) and CHILLS (chills). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. On 06-Aug-2021, PAIN (general aches and pains like she had the flu) had resolved. In August 2021, BACK PAIN (upper and lower back pain/pain in her upper back) and ARTHRALGIA (pain around her shoulders) had resolved. At the time of the report, VACCINATION SITE MASS (injection site was raised/raised bump at the injection site), VACCINATION SITE BRUISING (injection site bruised/bruising around the injection site), LETHARGY (lethargic), MALAISE (didn't feel good), VACCINATION SITE HAEMORRHAGE (bled a lot after the injection), NAUSEA (a little nauseous), VACCINATION SITE PAIN (injection site was tender to the touch/injection site pain/tender to the touch) and CHILLS (chills) outcome was unknown and VAGINAL HAEMORRHAGE (vaginal bleeding) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. Treatment includes Ice and Tea   This case was linked to MOD-2021-336033 (Patient Link).
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain, Vaginal haemorrhage
Clinical narrative: vaginal bleeding; lethargic; upper and lower back pain/pain in her upper back; didn't feel good; general aches and pains like she had the flu; a little nauseous; pain around her shoulders; chills; injection site was tender to the touch/injection site pain/tender to the touch; injection site was raised/raised bump at the injection site; injection site bruised/bruising around the injection site; bled a lot after the injection; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (injection site was raised/raised bump at the injection site), VACCINATION SITE BRUISING (injection site bruised/bruising around the injection site), VAGINAL HAEMORRHAGE (vaginal bleeding), LETHARGY (lethargic) and BACK PAIN (upper and lower back pain/pain in her upper back) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 091D21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 03-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Aug-2021, the patient experienced VACCINATION SITE MASS (injection site was raised/raised bump at the injection site), VACCINATION SITE BRUISING (injection site bruised/bruising around the injection site), VACCINATION SITE HAEMORRHAGE (bled a lot after the injection) and VACCINATION SITE PAIN (injection site was tender to the touch/injection site pain/tender to the touch). On 04-Aug-2021, the patient experienced VAGINAL HAEMORRHAGE (vaginal bleeding), LETHARGY (lethargic), BACK PAIN (upper and lower back pain/pain in her upper back), MALAISE (didn't feel good), PAIN (general aches and pains like she had the flu), NAUSEA (a little nauseous), ARTHRALGIA (pain around her shoulders) and CHILLS (chills). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. On 06-Aug-2021, PAIN (general aches and pains like she had the flu) had resolved. In August 2021, BACK PAIN (upper and lower back pain/pain in her upper back) and ARTHRALGIA (pain around her shoulders) had resolved. At the time of the report, VACCINATION SITE MASS (injection site was raised/raised bump at the injection site), VACCINATION SITE BRUISING (injection site bruised/bruising around the injection site), LETHARGY (lethargic), MALAISE (didn't feel good), VACCINATION SITE HAEMORRHAGE (bled a lot after the injection), NAUSEA (a little nauseous), VACCINATION SITE PAIN (injection site was tender to the touch/injection site pain/tender to the touch) and CHILLS (chills) outcome was unknown and VAGINAL HAEMORRHAGE (vaginal bleeding) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. Treatment includes Ice and Tea   This case was linked to MOD-2021-336033 (Patient Link).
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Malaise, Peripheral swelling, Pyrexia
Clinical narrative: swelling in the right arm and leg; swelling in the right arm and leg; Looks and feel terrible; fever of 102.2; This spontaneous case was reported by an other health care professional and describes the occurrence of the first episode of PERIPHERAL SWELLING (swelling in the right arm and leg), the second episode of PERIPHERAL SWELLING (swelling in the right arm and leg), MALAISE (Looks and feel terrible) and PYREXIA (fever of 102.2) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039D21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced the first episode of PERIPHERAL SWELLING (swelling in the right arm and leg), the second episode of PERIPHERAL SWELLING (swelling in the right arm and leg), MALAISE (Looks and feel terrible) and PYREXIA (fever of 102.2). The patient was treated with IBUPROFEN for Adverse event, at an unspecified dose and frequency. At the time of the report, last episode of PERIPHERAL SWELLING (swelling in the right arm and leg), MALAISE (Looks and feel terrible) and PYREXIA (fever of 102.2) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 102.2 (High) fever.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication were provided.
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: 3 patients received doses punctured past 12 hours; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (3 patients received doses punctured past 12 hours) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Sep-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (3 patients received doses punctured past 12 hours). On 24-Sep-2021, EXPIRED PRODUCT ADMINISTERED (3 patients received doses punctured past 12 hours) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication listed.   No treatment information provided.  Vial was punctured 12-16 hours prior while maintained at proper refrigerated temperature and protocol for revaccination.
Sex: M
Vaccine: COVID19
Symptoms: Chest wall cyst, Feeling abnormal, Hypoaesthesia, Inflammation, Paraesthesia
Clinical narrative: severe numbness in his right arm; tingling sensation that runs down his arm; feels debilitating; a cyst became inflamed; a cyst became inflamed; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (severe numbness in his right arm), PARAESTHESIA (tingling sensation that runs down his arm), FEELING ABNORMAL (feels debilitating), INFLAMMATION (a cyst became inflamed) and CHEST WALL CYST (a cyst became inflamed) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004F21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in November 2020. Concurrent medical conditions included Chest wall cyst.    On 01-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPOAESTHESIA (severe numbness in his right arm), PARAESTHESIA (tingling sensation that runs down his arm), FEELING ABNORMAL (feels debilitating), INFLAMMATION (a cyst became inflamed) and CHEST WALL CYST (a cyst became inflamed). At the time of the report, HYPOAESTHESIA (severe numbness in his right arm), PARAESTHESIA (tingling sensation that runs down his arm) and FEELING ABNORMAL (feels debilitating) outcome was unknown and INFLAMMATION (a cyst became inflamed) and CHEST WALL CYST (a cyst became inflamed) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported. No treatment medication use was reported. The second thing is he has a cyst on his chest that he's had for 4 years, but it became inflamed after the vaccination. It was acting up pretty severely that he went to his doctor who said it was from the vaccine. His doctor had to cut and drain the cyst and it seems fine now.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site mass
Clinical narrative: lump at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (lump at the injection site) in a 52-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 042B21A, 029L20A and 039K20A) for COVID-19 vaccination.     No Medical History information was reported.   On 23-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 21-Aug-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 21-Aug-2021, the patient experienced VACCINATION SITE MASS (lump at the injection site). At the time of the report, VACCINATION SITE MASS (lump at the injection site) outcome was unknown.            Concomitant and Treatment was not specified.   This case was linked to MOD-2021-336394 (Patient Link).
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea, Myalgia
Clinical narrative: GI effect - diarrhea; body aches; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (GI effect - diarrhea) and MYALGIA (body aches) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (GI effect - diarrhea) and MYALGIA (body aches). At the time of the report, DIARRHOEA (GI effect - diarrhea) and MYALGIA (body aches) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medication was reported No treatment medication was reported.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: 8 patients got expired vaccine; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (8 patients got expired vaccine) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Sep-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (8 patients got expired vaccine). On 28-Sep-2021, EXPIRED PRODUCT ADMINISTERED (8 patients got expired vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication was not provided. Treatment information was not provided.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Back disorder, Discomfort, Musculoskeletal discomfort, Pyrexia
Clinical narrative: Knocked her on her back; knot in her shoulder; a little discomfort; low grade fever; This spontaneous case was reported by a consumer and describes the occurrence of BACK DISORDER (Knocked her on her back), MUSCULOSKELETAL DISCOMFORT (knot in her shoulder), DISCOMFORT (a little discomfort) and PYREXIA (low grade fever) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 20-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Sep-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 26-Sep-2021, the patient experienced BACK DISORDER (Knocked her on her back), MUSCULOSKELETAL DISCOMFORT (knot in her shoulder), DISCOMFORT (a little discomfort) and PYREXIA (low grade fever). At the time of the report, BACK DISORDER (Knocked her on her back), MUSCULOSKELETAL DISCOMFORT (knot in her shoulder), DISCOMFORT (a little discomfort) and PYREXIA (low grade fever) outcome was unknown.            No concomitant medication details was reported. No treatment medication details was reported.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: 8 patients got expired vaccine; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (8 patients got expired vaccine) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (8 patients got expired vaccine). On 28-Sep-2021, EXPIRED PRODUCT ADMINISTERED (8 patients got expired vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was reported.  No treatment medication use was reported.
Age: 15.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: patient under 18 years got a dose of the Moderna vaccine; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (patient under 18 years got a dose of the Moderna vaccine) in a 15-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 939906) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 28-Sep-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (patient under 18 years got a dose of the Moderna vaccine). On 28-Sep-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (patient under 18 years got a dose of the Moderna vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication details were not reported by the reporter. Treatment details was not reported by the reporter.   This case was linked to MOD-2021-336648 (Patient Link).
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: 1st dose received on 21Jan2021 and 2nd dose received on 01Mar2021; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (1st dose received on 21Jan2021 and 2nd dose received on 01Mar2021) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032L20A and 022M20A) for COVID-19 vaccination.     The patient's past medical history included Heart attack (The patient had a heart attack 11 years ago prior to receiving the 1st dose of the moderna vaccine). Concurrent medical conditions included Heart disease, unspecified (The patient was a high-risk patient as he had a heart condition and heart attack 11 years ago prior to receiving the 1st dose of the moderna vaccine) and Hearing impaired (he had trouble hearing but stated that it was not due the vaccine.).   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 01-Mar-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (1st dose received on 21Jan2021 and 2nd dose received on 01Mar2021). On 01-Mar-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (1st dose received on 21Jan2021 and 2nd dose received on 01Mar2021) had resolved.            No concomitant medications reported. No treatment information was provided. The patient seemed upset and stated that he is confused with lack of information and so much confusion surrounding the 3rd dose and booster vaccine.
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired vaccine used; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 20-Sep-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   No concomitant medication listed.   No treatment information provided.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: administered a dose of the Moderna vaccine from the expired lot; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administered a dose of the Moderna vaccine from the expired lot) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (administered a dose of the Moderna vaccine from the expired lot). On 28-Sep-2021, EXPIRED PRODUCT ADMINISTERED (administered a dose of the Moderna vaccine from the expired lot) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. Treatment information was unknown.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Was administered an expired vaccine; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Was administered an expired vaccine) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025B21A) for COVID-19 vaccination.     No Medical History information was reported.   In 2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In 2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-Sep-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Was administered an expired vaccine). On 20-Sep-2021, EXPIRED PRODUCT ADMINISTERED (Was administered an expired vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. No treatment information was provided.
Sex: M
Vaccine: COVID19
Symptoms: Influenza like illness
Clinical narrative: Flu like symptoms for 12 hours after second Moderna covid-19 vaccine; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms for 12 hours after second Moderna covid-19 vaccine) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms for 12 hours after second Moderna covid-19 vaccine). At the time of the report, INFLUENZA LIKE ILLNESS (Flu like symptoms for 12 hours after second Moderna covid-19 vaccine) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not reported. treatment medications were not reported.   This case was linked to MOD-2021-336846 (Patient Link).
Age: 91.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Hypersomnia, Hypokinesia, Muscular weakness, Oedema peripheral
Clinical narrative: muscle weakness; hand tremors; difficulty getting out of a chair; sleeping up to 14 hours a day; pain in extremities-epecially the left arm; puffiness in her feet; extreme tiredness; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULAR WEAKNESS (muscle weakness), TREMOR (hand tremors), HYPOKINESIA (difficulty getting out of a chair), HYPERSOMNIA (sleeping up to 14 hours a day) and PAIN IN EXTREMITY (pain in extremities-epecially the left arm) in a 91-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Dementia since 2013, Hyperlipidemia and Arthritis. Concomitant products included DONEPEZIL for Dementia.    On 07-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In 2021, the patient experienced MUSCULAR WEAKNESS (muscle weakness), TREMOR (hand tremors), HYPOKINESIA (difficulty getting out of a chair), HYPERSOMNIA (sleeping up to 14 hours a day), PAIN IN EXTREMITY (pain in extremities-epecially the left arm), OEDEMA PERIPHERAL (puffiness in her feet) and FATIGUE (extreme tiredness). At the time of the report, MUSCULAR WEAKNESS (muscle weakness), TREMOR (hand tremors), HYPOKINESIA (difficulty getting out of a chair), HYPERSOMNIA (sleeping up to 14 hours a day), PAIN IN EXTREMITY (pain in extremities-epecially the left arm), OEDEMA PERIPHERAL (puffiness in her feet) and FATIGUE (extreme tiredness) had not resolved.            No concomitant medication was provided No treatment received by the patient   Most recent FOLLOW-UP information incorporated above includes: On 15-Aug-2021: Follow up document received  and contains no new information On 28-Sep-2021: ADR received on 28 Sep 2021,mentioned AE  outcome On 28-Sep-2021: follow up received  no new information; Sender's Comments: This case concerns a 91-year-old female patient with a relevant n medical history of dementia, who experienced the unexpected non-serious events of muscular weakness, tremor, hypokinesia, hypersomnia, pain in extremity, oedema peripheral and expected non-serious event of fatigue. The event covid19 occurred on the 8 months after receiving second dose of Moderna mRNA-1273 vaccine. The rechallenge is not applicable as the event Covid-19 occurred only after second dose. The reporter did not provide the causality assessment. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.
Age: 91.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Tremor
Clinical narrative: muscle weakness; hand tremors; difficulty getting out of a chair; sleeping up to 14 hours a day; pain in extremities-epecially the left arm; puffiness in her feet; extreme tiredness; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULAR WEAKNESS (muscle weakness), TREMOR (hand tremors), HYPOKINESIA (difficulty getting out of a chair), HYPERSOMNIA (sleeping up to 14 hours a day) and PAIN IN EXTREMITY (pain in extremities-epecially the left arm) in a 91-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Dementia since 2013, Hyperlipidemia and Arthritis. Concomitant products included DONEPEZIL for Dementia.    On 07-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In 2021, the patient experienced MUSCULAR WEAKNESS (muscle weakness), TREMOR (hand tremors), HYPOKINESIA (difficulty getting out of a chair), HYPERSOMNIA (sleeping up to 14 hours a day), PAIN IN EXTREMITY (pain in extremities-epecially the left arm), OEDEMA PERIPHERAL (puffiness in her feet) and FATIGUE (extreme tiredness). At the time of the report, MUSCULAR WEAKNESS (muscle weakness), TREMOR (hand tremors), HYPOKINESIA (difficulty getting out of a chair), HYPERSOMNIA (sleeping up to 14 hours a day), PAIN IN EXTREMITY (pain in extremities-epecially the left arm), OEDEMA PERIPHERAL (puffiness in her feet) and FATIGUE (extreme tiredness) had not resolved.            No concomitant medication was provided No treatment received by the patient   Most recent FOLLOW-UP information incorporated above includes: On 15-Aug-2021: Follow up document received  and contains no new information On 28-Sep-2021: ADR received on 28 Sep 2021,mentioned AE  outcome On 28-Sep-2021: follow up received  no new information; Sender's Comments: This case concerns a 91-year-old female patient with a relevant n medical history of dementia, who experienced the unexpected non-serious events of muscular weakness, tremor, hypokinesia, hypersomnia, pain in extremity, oedema peripheral and expected non-serious event of fatigue. The event covid19 occurred on the 8 months after receiving second dose of Moderna mRNA-1273 vaccine. The rechallenge is not applicable as the event Covid-19 occurred only after second dose. The reporter did not provide the causality assessment. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Headache, Illness, Insomnia
Clinical narrative: she got sick; her skin hurt; didn't sleep well; headache; body aches; fever 100.9 degrees F; chills; This spontaneous case was reported by an other health care professional and describes the occurrence of ILLNESS (she got sick), PAIN OF SKIN (her skin hurt), INSOMNIA (didn't sleep well), HEADACHE (headache) and MYALGIA (body aches) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 052E21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included HIV infection (which patient contracted from her husband.), Chronic fatigue, Chronic bronchitis, Chronic pneumonia, Degenerative joint disease, Seasonal allergy, Penicillin allergy and Immunocompromised. Concomitant products included FLUTICASONE PROPIONATE (FLONASE [FLUTICASONE PROPIONATE]) for Allergy, HYDROCODONE BITARTRATE, PARACETAMOL (VICODIN) for Degenerative joint disease, BICTEGRAVIR SODIUM, EMTRICITABINE, TENOFOVIR ALAFENAMIDE FUMARATE (BIKTARVY) for HIV disease, EPINEPHRINE (EPIPEN) for an unknown indication.    On 20-Aug-2021 at 12:45 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Aug-2021 at 8:00 PM, the patient experienced ILLNESS (she got sick), INSOMNIA (didn't sleep well) and HEADACHE (headache). 20-Aug-2021 at 8:00 PM, the patient experienced PAIN OF SKIN (her skin hurt). 20-Aug-2021 at 8:00 PM, the patient experienced MYALGIA (body aches), PYREXIA (fever 100.9 degrees F) and CHILLS (chills). On 22-Aug-2021, ILLNESS (she got sick), PAIN OF SKIN (her skin hurt), INSOMNIA (didn't sleep well), HEADACHE (headache), MYALGIA (body aches), PYREXIA (fever 100.9 degrees F) and CHILLS (chills) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 20-Aug-2021, Body temperature: 100.9 (High) At 8 PM, 100.9 degrees F.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient treatment information include no medication for events.   This case was linked to MOD-2021-337213 (Patient Link).
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Pain of skin, Pyrexia
Clinical narrative: she got sick; her skin hurt; didn't sleep well; headache; body aches; fever 100.9 degrees F; chills; This spontaneous case was reported by an other health care professional and describes the occurrence of ILLNESS (she got sick), PAIN OF SKIN (her skin hurt), INSOMNIA (didn't sleep well), HEADACHE (headache) and MYALGIA (body aches) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 052E21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included HIV infection (which patient contracted from her husband.), Chronic fatigue, Chronic bronchitis, Chronic pneumonia, Degenerative joint disease, Seasonal allergy, Penicillin allergy and Immunocompromised. Concomitant products included FLUTICASONE PROPIONATE (FLONASE [FLUTICASONE PROPIONATE]) for Allergy, HYDROCODONE BITARTRATE, PARACETAMOL (VICODIN) for Degenerative joint disease, BICTEGRAVIR SODIUM, EMTRICITABINE, TENOFOVIR ALAFENAMIDE FUMARATE (BIKTARVY) for HIV disease, EPINEPHRINE (EPIPEN) for an unknown indication.    On 20-Aug-2021 at 12:45 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Aug-2021 at 8:00 PM, the patient experienced ILLNESS (she got sick), INSOMNIA (didn't sleep well) and HEADACHE (headache). 20-Aug-2021 at 8:00 PM, the patient experienced PAIN OF SKIN (her skin hurt). 20-Aug-2021 at 8:00 PM, the patient experienced MYALGIA (body aches), PYREXIA (fever 100.9 degrees F) and CHILLS (chills). On 22-Aug-2021, ILLNESS (she got sick), PAIN OF SKIN (her skin hurt), INSOMNIA (didn't sleep well), HEADACHE (headache), MYALGIA (body aches), PYREXIA (fever 100.9 degrees F) and CHILLS (chills) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 20-Aug-2021, Body temperature: 100.9 (High) At 8 PM, 100.9 degrees F.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient treatment information include no medication for events.   This case was linked to MOD-2021-337213 (Patient Link).